Potency analysis of peptide, lysate and apoptotic cells as sources of tumor antigen(s) in dendritic cell-based vaccine immunotherapy in vivo.

被引：0
|
作者：
Shimizu, K
Kotera, Y
Mulé, JJ
机构：
[1] Tokyo Womens Med Coll, Sinjuku Ku, Tokyo 1662, Japan
[2] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
FASEB JOURNAL | 2001年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1207 / A1207
页数：1
相关论文
共 50 条
  • [21] Adoptive immunotherapy combined with a dendritic cell-based vaccine results in the rejection of established tumor in a murine melanoma model
    Koike, N
    Kuhn, L
    Pilon-Thomas, SA
    Mulé, JJ
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 614 - 614
  • [22] Specific antitumor effect of a dendritic cell-based vaccine loaded with photodynamically treated tumor cells
    Dai, Q. Y.
    Guerin, M.
    Maldonado, C.
    Scotto, C.
    Roy, D. C.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 54 - 54
  • [23] Apoptotic cell-based therapies against transplant rejection: role of recipient’s dendritic cells
    Adrian E. Morelli
    Adriana T. Larregina
    Apoptosis, 2010, 15 : 1083 - 1097
  • [24] Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells
    Morelli, Adrian E.
    Larregina, Adriana T.
    APOPTOSIS, 2010, 15 (09) : 1083 - 1097
  • [25] Safety of an autologous glial tumor lysate-pulsed, dendritic cell-based vaccine in combination with thalidomide for patients with relapsed malignant gliomas
    Ty, Albert
    Wang, Who Whong
    Toh, Han Chong
    Zhu, Cong Ju
    Kang, Khong Bee
    Wong, Meng Cheong
    NEURO-ONCOLOGY, 2007, 9 (04) : 509 - 510
  • [26] Multi-stage silicon vector delivered tumor antigen and TLR ligands for dendritic cell-based cancer immunotherapy
    Xia, Xiaojun
    Ferrari, Mauro
    Shen, Haifa
    CANCER RESEARCH, 2012, 72
  • [27] IMMUNOGENICITY OF ALLO-VESICLE CARRYING ERBB2 TUMOR ANTIGEN FOR DENDRITIC CELL-BASED ANTI-TUMOR IMMUNOTHERAPY
    Napoletano, C.
    Rughetti, A.
    Landi, R.
    Pinto, D.
    Bellati, F.
    Rahimi, H.
    Spinelli, G. P.
    Pauselli, S.
    Sale, P.
    Dolo, V.
    De Lorenzo, F.
    Tomao, F.
    Benedetti-Panici, P.
    Frati, L.
    Nuti, M.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2009, 22 (03) : 647 - 658
  • [28] Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells
    Lenogue, Kevin
    Walencik, Alexandre
    Laulagnier, Karine
    Molens, Jean-Paul
    Benlalam, Houssem
    Dreno, Brigitte
    Coulie, Pierre
    Pule, Martin
    Chaperot, Laurence
    Plumas, Joel
    VACCINES, 2021, 9 (02) : 1 - 15
  • [29] Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccine
    Chang, EY
    Chen, CH
    Ji, HX
    Wang, TL
    Hung, K
    Lee, BP
    Huang, AYC
    Kurman, RJ
    Pardoll, DM
    Wu, TC
    INTERNATIONAL JOURNAL OF CANCER, 2000, 86 (05) : 725 - 730
  • [30] Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy
    Yazdani, Mona
    Gholizadeh, Zahra
    Nikpoor, Amin Reza
    Roshan, Nema Mohamadian
    Jaafari, Mahmoud Reza
    Badiee, Ali
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345